-
Shariska Petersen, MD,
University of Kansas Medical Center Research Institute
Mentored Investigator Grant
Cyclin E and BRD4 as Markers for a New PARPi Drug Combination
-
Alba Rodriguez-Garcia, PhD,
University of Pennsylvania
Mentored Investigator Grant
Targeting MISIIR with CAR T Cells for the Treatment of Ovarian Cancer
-
Elaine Stur, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Re-activating Anti-tumor Immunity Targeting PSEN1 in CAFS in Ovarian Cancer
-
Shuai Wu, PhD,
The Wistar Institute
Mentored Investigator Grant
Synthetic Lethality for ARID1A Mutation in Ovarian Cancer
-
Min Soon Cho, PhD,
MD Anderson Cancer Center
Early Career Investigator Grant
The Role of Platelet in the Regulation of Immune Response to Ovarian Cancer
-
Haineng Xu, PhD,
University of Pennsylvania
Mentored Investigator Grant
A Novel Targeted Therapy for Cyclin E Over Expressing Ovarian Cancers
-
Zihua Gong, MD, PhD,
Cleveland Clinic
Early Career Investigator Grant
DNA Repair Pathways as Targets for Therapy-Resistant Ovarian Cancer
-
Xiaowen Hu, PhD,
University of Pennsylvania
Early Career Investigator Grant
Targeting Chromatin Remodeling Complex to Treat Ovarian Cancer
-
Kate Lawrenson, PhD,
Cedars-Sinai Medical Center
Early Career Investigator Grant
Elucidating the Role of SOX17 in HGSOC
-
Elizabeth Stover, MD, PhD,
Dana Farber Cancer Institute
Early Career Investigator Grant
Targeting Anti-apoptotic Proteins BCL-XL and MCL-1 in Serous Ovarian Cancer
-
Takemasa Tsuji, PhD,
Roswell Park Comprehensive Cancer Center
Early Career Investigator Grant
Utilization of Tumor-recognizing CD4+T Cells in Cancer Immunotherapy
-
Kris Wood, PhD,
Duke University
Early Career Investigator Grant
Precision Targeting of Altered Mitochondrial States in Ovarian Cancer